You are here: All Products  > Keymed Stages $378 Million Hong Kong IPO for Antibody Portfolio

Keymed Stages $378 Million Hong Kong IPO for Antibody Portfolio

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.